[Gastric functional exploration. Comparison between secretory results in 72 non-ulcer dyspeptic patients and 289 non-operated duodenal ulcer patients. Predictive criteria for the efficacy of fundus vagotomy in duodenal ulcer]. 1991

J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
Service d'Hépato-Gastroentérologie, CHU Xavier-Bichat, Paris.

Basal and pentagastrin- or insulin- stimulated secretion was studied in 72 non ulcer dyspectic patients (NUD), in 289 non operated duodenal ulcer patients (DU), and in 30 DU, before and after highly selective vagotomy (HSV). Acidity, proteolytic activity, choline indicating the presence of duodenogastric refluxed material and sialic acid bound to mucus glycoprotein, marker of mucus erosion, were measured. Basal and pentagastrin-stimulated acid and pepsin secretions in NUD were significantly reduced with regard to those in DU. Sialic acid content was weak in basal secretion and markedly increased in response to pentagastrin reaching the values observed in DU. DU basal secretions of acid and of pepsin were modulated according to the stimulating secretory mechanism. Mucus glycoprotein erosion was related to pepsin mucolytic activity and/or to the presence in gastric juice of refluxed material. In DU the increase of peptic mucolysis corresponded to a biological signal of the ulcer attack when no duodenogastric reflux was identified. High values pepsin output in basal secretion and in response to insulin and of basal sialic acid content combined with a pepsin/acid basal output ratio higher than 80 were biological arguments anticipating the efficacy of HSV in DU. Multiparametric analysis of gastric secretion allows to evaluate the ratio between aggressive factors and mucosal defense corresponding to an equilibrium in NUD and to greater aggressivity in DU whose intensity is related to the course of disease.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D010434 Pepsin A Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice. Pepsin,Pepsin 1,Pepsin 3
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002794 Choline A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Bursine,Fagine,Vidine,2-Hydroxy-N,N,N-trimethylethanaminium,Choline Bitartrate,Choline Chloride,Choline Citrate,Choline Hydroxide,Choline O-Sulfate,Bitartrate, Choline,Chloride, Choline,Choline O Sulfate,Citrate, Choline,Hydroxide, Choline,O-Sulfate, Choline
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D005260 Female Females

Related Publications

J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
June 1984, World journal of surgery,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
January 1969, Acta chirurgica Scandinavica. Supplementum,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
January 1970, Scandinavian journal of gastroenterology,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
January 1986, Annales chirurgiae et gynaecologiae,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
January 1986, Klinicheskaia khirurgiia,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
January 1966, Revue internationale d'hepatologie,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
May 1978, Annals of surgery,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
May 1971, Lancet (London, England),
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
February 1977, Revista espanola de las enfermedades del aparato digestivo,
J Vatier, and C Poitevin, and M C Pasquier, and M T Vitré, and A Olivier, and D Sfedj, and M Mignon
October 1987, Minerva chirurgica,
Copied contents to your clipboard!